看2026｜天智航黄军辉：拓展基层医疗市场，寻求新增长曲线

Core Viewpoint - The article discusses the strategic development goals and initiatives of Tianzhihang in response to the central economic work conference's call for expanding domestic demand and optimizing supply in the context of the 2026 economic landscape [2][5]. Group 1: Initiatives for Expanding Domestic Demand - The company aims to deepen market penetration by responding to the call for expanding domestic demand, focusing on the tertiary hospital market while accelerating expansion into secondary hospitals and grassroots medical markets [5]. - The company plans to enhance clinical training and academic promotion to lower application barriers and increase the penetration rate of surgical robots in medical institutions [5]. Group 2: Optimizing Product and Service Quality - The company will continue to upgrade its "Tianji" series orthopedic surgical robots to improve precision, intelligence, and usability [6]. - It intends to diversify its product line by exploring applications in more orthopedic subfields such as spine, joints, and trauma, while also building a comprehensive clinical support, training, and maintenance system [6]. Group 3: Strengthening Technological Innovation - The company identifies the development of new productive forces as a core driver, planning to increase R&D investment focused on advanced technologies like precise navigation for orthopedic surgery and 5G remote surgery [6]. - Collaborations with top medical institutions and research institutes will be pursued to explore new clinical techniques and applications, translating technological innovation into advanced productivity that benefits a broader patient base [6]. Group 4: Strategic Development Goals for 2026 - The company aims for steady growth in revenue and market share, maintaining its leading position in the Chinese orthopedic surgical robot market through market penetration and overseas exploration [7]. - The product innovation goal includes launching a more intelligent and modular orthopedic surgical robot system based on the existing "Tianji" platform, achieving breakthroughs in key technologies [7]. - The core business line will continue to deepen, focusing on the full-chain value from equipment to service, and exploring digital medical solutions based on the surgical robot platform [7].